 |
PDBsum entry 4ps3
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
4ps3
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase/transferase inhibitor
|
 |
|
Title:
|
 |
Structure of pi3k gamma in complex with 1-[6-(5-methoxypyridin-3-yl)- 1,3-benzothiazol-2-yl]-3-[2-(1-propyl-1h-imidazol-4-yl)ethyl]urea
|
|
Structure:
|
 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform. Chain: a. Fragment: catalytic domain (unp residues 144-1102). Synonym: pi3-kinase subunit gamma, pi3k-gamma, pi3kgamma, ptdins-3- kinase subunit gamma, phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kda catalytic subunit gamma, ptdins-3-kinase subunit p110-gamma, p110gamma, phosphoinositide-3-kinase catalytic gamma polypeptide, serine/threonine protein kinase pik3cg, p120-pi3k.
|
|
Source:
|
 |
Homo sapiens. Human. Organism_taxid: 9606. Gene: pi3k gamma, pik3cg. Expressed in: spodoptera frugiperda. Expression_system_taxid: 7108. Expression_system_cell_line: sf21.
|
|
Resolution:
|
 |
|
2.90Å
|
R-factor:
|
0.214
|
R-free:
|
0.259
|
|
|
Authors:
|
 |
J.P.Griffith
|
|
Key ref:
|
 |
P.N.Collier
et al.
(2015).
Structural basis for isoform selectivity in a class of benzothiazole inhibitors of phosphoinositide 3-kinase γ.
J Med Chem,
58,
517-521.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
06-Mar-14
|
Release date:
|
14-May-14
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P48736
(PK3CG_HUMAN) -
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform from Homo sapiens
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1102 a.a.
843 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.2.7.11.1
- non-specific serine/threonine protein kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
|
1.
|
L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H+
|
|
2.
|
L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H+
|
|
 |
 |
 |
 |
 |
L-seryl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-seryl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
L-threonyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-threonyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
E.C.2.7.1.137
- phosphatidylinositol 3-kinase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) + ATP = a 1,2-diacyl- sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate) + ADP + H+
|
 |
 |
 |
 |
 |
1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol)
|
+
|
ATP
|
=
|
1,2-diacyl- sn-glycero-3-phospho-(1D-myo-inositol-3-phosphate)
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
E.C.2.7.1.153
- phosphatidylinositol-4,5-bisphosphate 3-kinase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate) + ATP = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5- trisphosphate) + ADP + H+
|
 |
 |
 |
 |
 |
1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-4,5-bisphosphate)
|
+
|
ATP
|
=
|
1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4,5- trisphosphate)
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 5:
|
 |
E.C.2.7.1.154
- phosphatidylinositol-4-phosphate 3-kinase.
|
|
 |
 |
 |
 |
 |

Pathway:
|
 |
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate) + ATP = a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4-bisphosphate) + ADP + H+
|
 |
 |
 |
 |
 |
1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate)
|
+
|
ATP
|
=
|
1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol-3,4-bisphosphate)
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Med Chem
58:517-521
(2015)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural basis for isoform selectivity in a class of benzothiazole inhibitors of phosphoinositide 3-kinase γ.
|
|
P.N.Collier,
G.Martinez-Botella,
M.Cornebise,
K.M.Cottrell,
J.D.Doran,
J.P.Griffith,
S.Mahajan,
F.Maltais,
C.S.Moody,
E.P.Huck,
T.Wang,
A.M.Aronov.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Phosphoinositide 3-kinase γ (PI3Kγ) is an attractive target to potentially
treat a range of disease states. Herein, we describe the evolution of a reported
phenylthiazole pan-PI3K inhibitor into a family of potent and selective
benzothiazole inhibitors. Using X-ray crystallography, we discovered that
compound 22 occupies a previously unreported hydrophobic binding cleft adjacent
to the ATP binding site of PI3Kγ, and achieves its selectivity by exploiting
natural sequence differences among PI3K isoforms in this region.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |